7EKB image
Entry Detail
PDB ID:
7EKB
Keywords:
Title:
Crystal structure of 4E10 modified with pyrene acetamide
Biological Source:
PDB Version:
Deposition Date:
2021-04-05
Release Date:
2021-08-11
Method Details:
Experimental Method:
Resolution:
1.45 Å
R-Value Free:
0.15
R-Value Work:
0.11
R-Value Observed:
0.12
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Fab region of the heavy chain of broadly neutralizing antibody anti-HIV-1 4E10
Chain IDs:A (auth: H)
Chain Length:228
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Fab region of the light chain of the broadly neutralizing anti-HIV-1 antibody 4E10
Chain IDs:B (auth: L)
Chain Length:214
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:MPER region of the HIV-1 envelope glycoprotein protein gp41
Chain IDs:C (auth: P)
Chain Length:16
Number of Molecules:1
Biological Source:Human immunodeficiency virus 1
Primary Citation
Focal accumulation of aromaticity at the CDRH3 loop mitigates 4E10 polyreactivity without altering its HIV neutralization profile.
Iscience 24 102987 102987 (2021)
PMID: 34505005 DOI: 10.1016/j.isci.2021.102987

Abstact

Broadly neutralizing antibodies (bnAbs) against HIV-1 are frequently associated with the presence of autoreactivity/polyreactivity, a property that can limit their use as therapeutic agents. The bnAb 4E10, targeting the conserved Membrane proximal external region (MPER) of HIV-1, displays almost pan-neutralizing activity across globally circulating HIV-1 strains but exhibits nonspecific off-target interactions with lipid membranes. The hydrophobic apex of the third complementarity-determining region of the heavy chain (CDRH3) loop, which is essential for viral neutralization, critically contributes to this detrimental effect. Here, we have replaced the aromatic/hydrophobic residues from the apex of the CDRH3 of 4E10 with a single aromatic molecule through chemical modification to generate a variant that preserves the neutralization potency and breadth of 4E10 but with reduced autoreactivity. Collectively, our study suggests that the localized accumulation of aromaticity by chemical modification provides a pathway to ameliorate the adverse effects triggered by the CDRH3 of anti-HIV-1 MPER bnAbs.

Legend

Protein

Chemical

Disease

Primary Citation of related structures